Upload
barry-richardson
View
218
Download
0
Tags:
Embed Size (px)
Citation preview
Pregnancy DiagnosisPregnancy Diagnosis
Obstetrics and Gynecology Hospital of FudanUniversityXing Chen, MD.Email: [email protected]
For a woman with regular menstrual cycles, a history of one or more missed periods following a time of sexual activity without effective contraception strongly suggests early pregnancy
Associated Symptoms
Fatigue
Nausea/vomiting
Breast tenderness
physical examination
softening and enlargement of the pregnant uteruscongestion and a bluish discoloration of the vagina (Chadwick sign)
softening of the cervix (Hegar sign)
Increased pigmentation of the skinappearance of circumlinear striae on the abdominal wall (striae gravidarum )
Palpation of fetal parts
appreciation of fetal movement and fetal heart tones
Pregnancy testhuman chorionic gonadotropin (hCG): α/β-subunitproduced in the syncytiotrophoblast
Urineapproximately 4 weeks following the first day of the last menstrual period
All urine pregnancy tests are best performed on early-morning urine specimens, which contain the highest concentration of hCG
Serumspecific and sensitive
by following serial quantitative hCG levels and comparing them to the expected rise derived from normative data for proven normal intrauterine pregnancies
Ultrasound examination
Abdominal ultrasound allowing visualization of a normal pregnancy gestational sac 5 to 6 weeks after the beginning of the last normal menstrual period (corresponding to β-hCG concentrations of 5000 to 6000 mIU/mL)Transvaginal ultrasound often detects pregnancy at 3 to 4 weeks of gestation (corresponding to β-hCG concentrations of 1000 to 2000 mIU/mL)
Detection of fetal heart activity “fetal heart tones”
Acoustic fetoscope
beyond 18 to 20 weeks of gestational age
Electronic Doppler devices
approximately 12 weeks of gestation
Abnormal Pregnancy
Spontaneous abortion
Ectopic pregnancy
Trophoblastic disease
Prenatal Diagnosis Prenatal Diagnosis
Prenatal diagnosisPrenatal diagnosisis the science of identifying is the science of identifying
structural or functional structural or functional abnormalities-birth defects-in abnormalities-birth defects-in
the fetusthe fetus
Etiology of Birth DefectsEtiology of Birth Defects
MalformationMalformation
DeformationDeformation
DisruptionDisruption
OtherOther
MalformationMalformation
an intrinsic abnormality "programmed" in dan intrinsic abnormality "programmed" in development, regardless of whether a precievelopment, regardless of whether a precise genetic etiology is knownse genetic etiology is known
spina bifidaspina bifida
DeformationDeformation
caused when a genetically normal fetus decaused when a genetically normal fetus develops abnormally because of mechanical velops abnormally because of mechanical forces imposed by the uterine environmentforces imposed by the uterine environment
normal limb that develops contractures benormal limb that develops contractures because of prolonged oligohydramnioscause of prolonged oligohydramnios
DisruptionDisruption
which is a more severe change in form or fwhich is a more severe change in form or function that occurs when genetically normunction that occurs when genetically normal tissue is modified as the result of a specal tissue is modified as the result of a specific insultific insult
an amnionic band causing a cephalocele oan amnionic band causing a cephalocele or limb-reduction abnormalityr limb-reduction abnormality
OtherOther
Syndrome: Syndrome: trisomy 18trisomy 18
Sequence: Sequence: oligohydramnios leading to puloligohydramnios leading to pulmonary hypoplasiamonary hypoplasia
AssociationAssociation: VATER (association of : VATER (association of vvertebertebral defects, anal ral defects, anal aatresia, tresia, ttracheoesophageracheoesophageal fistula with al fistula with eesophageal atresia, and sophageal atresia, and rradiadial dysplasia)al dysplasia)
Techniques
Non-invasive
Minimally invasive
Invasive
Non-invasive techniques
Ultrasound
Magnetic Resonance Imaging (MRI)
Minimally Invasive Techniques
Cell free fetal DNA (cffDNA)
Pre-implantation genetic diagnosis (PGD)
Invasive Techniques
Chorionic villus sampling (CVS)
Amniocentesis
Percutaneous umbilical blood sampling (cordocentesis)
Key Guidelines
All women contemplating any form of prenatal diagnosis should be adequately counselled about the risks, benefits and limitations of any test, and provided with non-directional written information
Screening test for Down's syndrome and ‘20 week’ scan for structural anomalies
Women at risk of having a baby with congenital heart disease should be offered an extra fetal echocardiogram at 21–24 weeks
The middle cerebral artery Doppler peak systolic velocity can be used as a non-invasive method for diagnosing of fetal anaemia
Key Guidelines
Serial ultrasound measurements are of undoubted use in monitoring fetal growth but all formulae currently used to estimate fetal weight are inherently flawed and may give errors up to ±14%
MRI is a useful adjunct to ultrasound in prenatal diagnosis especially in the diagnosis of intra-cranial, intra-thoracic and gastrointestinal anomalies
Key Guidelines
Cell free fetal DNA testing has become widely established for the management of Rhesus disease and certain sex linked genetic disorders. With further research it is poised to offer much greater benefits in the field of minimally invasive prenatal diagnosis
Pre-implantation genetic diagnosis provides the opportunity for parents to avoid the distress of invasive testing and possible termination. However, the ethical and legal debate is set to continue for many years
Key Guidelines
CVS should not be performed before 10 weeks of gestation as it has been associated with limb reduction abnormalities. It appears to be safer if it is performed transabdominally rather than transcervically
Amniocentesis should not be performed at less than 15 weeks of gestation as before this it is associated with greater risk of pregnancy loss and possible talipes in the fetus
Key Guidelines
In experienced hands CVS and amniocentesis both carry a similar procedure related risk of miscarriage of 0.5–1%
Percutaneous umbilical blood sampling is now limited to potentially lifesaving in utero transfusion procedures for severe fetal anaemia
Neural-Tube Defects (NTDs)Neural-Tube Defects (NTDs)
anencephalyanencephaly, , spina bifidaspina bifida, , cephalocelcephalocele, ane, and other rare spinal fusion (d other rare spinal fusion (schisisschisis) abnorm) abnormalitiesalities
had higher levels of alpha-fetoprotein (had higher levels of alpha-fetoprotein (AFAFPP) in maternal serum and amnionic fluid) in maternal serum and amnionic fluid
Maternal Serum AFP ScreeningMaternal Serum AFP Screening
influence factors: maternal weight, gestational age, diabetes, multifetal gestation
Evaluation of Maternal Serum AFP ElevationEvaluation of Maternal Serum AFP Elevation
genetic counselinggenetic counseling
diagnostic testdiagnostic test Specialized SonographySpecialized Sonography amniocentesisamniocentesis
Specialized SonographySpecialized Sonography
Transverse and sagittal images of the spinTransverse and sagittal images of the spine are increasingly used to characterize the e are increasingly used to characterize the size and location of spinal defectssize and location of spinal defects
AmniocentesisAmniocentesis
amnionic fluid AFP levelamnionic fluid AFP level
assay for acetylcholinesteraseassay for acetylcholinesterase
Down Syndrome Down Syndrome
trisomy 18, 21trisomy 18, 21
First/second trimester: Sonography and mFirst/second trimester: Sonography and maternal serum markersaternal serum markers
Second-Trimester ScreeningSecond-Trimester Screening
At 15 to 20 weeksAt 15 to 20 weeks
Triple test: Triple test: MSAFP (maternal serum alpha-fetoprotein )MSAFP (maternal serum alpha-fetoprotein ) hCG or freehCG or freeββ-hCG-hCG uE3 (unconjugated estriol )uE3 (unconjugated estriol )
Quadruple (Quad) test: Quadruple (Quad) test:
+ inh (dimeric inhibin alpha)+ inh (dimeric inhibin alpha)
First-Trimester ScreeningFirst-Trimester Screening
between 11 and 14 weeksbetween 11 and 14 weeks
maternal serum analyte screening: maternal serum analyte screening: hCG (or free hCG (or free ββ--hCG) hCG) pregnancy-associated plasma protein A (PAPP-A) pregnancy-associated plasma protein A (PAPP-A)
sonographic: nuchal translucency (NT)sonographic: nuchal translucency (NT)
combination of bothcombination of both
Be aware…Be aware…
gestational age affects the accuracygestational age affects the accuracy
less sensitive in younger womenless sensitive in younger women
Be aware…Be aware…
strong association between increasing nucstrong association between increasing nuchal translucency and fetal cardiac anomalihal translucency and fetal cardiac anomalieses
nuchal translucency measurement is 3.5 nuchal translucency measurement is 3.5 mm or greater with a normal fetal karyotypmm or greater with a normal fetal karyotype, then targeted sonographic examination, e, then targeted sonographic examination, fetal echocardiography, or both should be fetal echocardiography, or both should be consideredconsidered
Sonographic Screening for AneuploidySonographic Screening for Aneuploidy
Major Structural DefectsMajor Structural Defects
"Soft Signs" "Soft Signs"
Diagnostic TechniquesDiagnostic Techniques
Second-Trimester AmniocentesisSecond-Trimester Amniocentesis between 15 and 20 weeksbetween 15 and 20 weeks
Early AmniocentesisEarly Amniocentesis between 11 and 14 weeksbetween 11 and 14 weeks
Chorionic Villus Sampling (CVS)Chorionic Villus Sampling (CVS) at 10 to 13 weeksat 10 to 13 weeks
Fetal Blood SamplingFetal Blood Sampling percutaneous umbilical blood sampling (PUBS) or cordopercutaneous umbilical blood sampling (PUBS) or cordo
centesiscentesis
Fetal Tissue BiopsyFetal Tissue BiopsyPreimplantation Genetic DiagnosisPreimplantation Genetic DiagnosisFetal Cells in the Maternal CirculationFetal Cells in the Maternal Circulation
Fetal Therapy Fetal Therapy -to improve the intrauterine environment-to improve the intrauterine environment
blood product transfusionblood product transfusion
administration of medication transplacentaladministration of medication transplacentally or via the fetal circulationly or via the fetal circulation
laser or radiofrequency ablation of vasculalaser or radiofrequency ablation of vascular anastomosesr anastomoses
amnioreductionamnioreduction
shunt placementshunt placement
fetal surgeryfetal surgery
ReferenceReference
Obstetrics and Gynecology, 6th edition
Williams Obstetrics, 23rd edition
Prenatal diagnosis: Types and techniques. Early Human Development. 2012 (88) :3–8